Interv Akut Kardiol. 2007;6(2):39-40

Drug-eluting stents - reviewing the review

Michael Želízko
Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

-

Keywords: -

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Želízko M. Drug-eluting stents - reviewing the review. Interv Akut Kardiol. 2007;6(2):39-40.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Stone GW, Moses JW, Ellis SG. Safety and efficacy of sirolimus and paclitaxel eluting coronary stents. N Engl J Med 2007;356:998-1008. Go to original source... Go to PubMed...
    2. Mauri L, Hsieh W, Massaro JM. Stent thrombosis in randomized clinical trials of drug eluting stents. N Engl J Med 2007;356:1020-1029. Go to original source... Go to PubMed...
    3. Spaulding CH, Daemen J, Boersma E. A pooled analysis of data comparing sirolimus eluting stents with bare metal stents. N Engl J Med 2007;356:989-997. Go to original source... Go to PubMed...
    4. Kastrati A, Mehili J, Pache J. Analysis of 14 trials comparing sirolimus eluting stents with bare metal stents. N Engl J Med 2007;356:1030-1039. Go to original source... Go to PubMed...
    5. Lagerquist B, James SK, Stenestrand U. Long term outcomes with drug eluting stents versus bare metal stents in Sweden. N Engl J Med 2007;356:1009-1019. Go to original source... Go to PubMed...
    6. Maeng M. Western Denmark registry results. ACC 2007 Scientific Sessions, March 27, 2007.
    7. Dangas GD. The MATRIX Registry. ACC 2007 Scientific Sessions, March 26, 2007.
    8. Serryus PW. The ARTS II study. ACC 2007 Scientific Sessions, March 26, 2007.

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.